Delivery methods and compositions for nuclease-mediated genome engineering in hematopoietic stem cells
US10117899B2 · kind B2 · utility
0Cited by
44References
11Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Oct 16, 2014 |
| Grant date | Nov 6, 2018 |
| Priority date | — |
| Expiry date | Jul 14, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2740/16043
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure is in the field of genome engineering, particularly targeted modification of the genome of a hematopoietic cell.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.